vimarsana.com

Page 8 - சுவிஸ் நிதி சேவைகள் நாடகம் துடுப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQS-News: Jacobs Holding AG: Jacobs Holding schliesst Platzierung von 550 000 Aktien von Barry Callebaut durch ein beschleunigtes Bookbuilding-Verfahren erfolgreich ab

EQS-News: Jacobs Holding AG: Jacobs Holding schliesst Platzierung von 550 000 Aktien von Barry Callebaut durch ein beschleunigtes Bookbuilding-Verfahren erfolgreich ab
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

Jacobs Holding AG: Jacobs Holding launches placement of 550,000 shares in Barry Callebaut in an accelerated bookbuilding

Nachricht vom 27.04.2021 | 17:52 Jacobs Holding AG: Jacobs Holding launches placement of 550,000 shares in Barry Callebaut in an accelerated bookbuilding EQS Group-News: Jacobs Holding AG / Key word(s): Investment 27.04.2021 / 17:52 NOT FOR RELEASE, PUBLICATION, CIRCULATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR IN ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Jacobs Holding launches placement of 550,000 shares in Barry Callebaut in an accelerated bookbuilding Jacobs Holding prepares to seize further investment opportunities while remaining reference shareholder of Barry Callebaut and committed for the long-term Zurich, 27 April 2021 - Jacobs Holding AG (Jacobs Holding) announces the launch of an accelerated bookbuilding process of 550,000 Barry Callebaut shares (10.0% of Barry Callebaut s share capital). With a remaining stake of 30.1%, Jacobs Holding will stay ful

Investegate |Santhera Pharmaceuticals Holdi Announcements | Santhera Pharmaceuticals Holdi: Santhera Reports End Results on Convertible Bond Exchange Offer

Santhera Reports Interim Results on Convertible Bond Exchange Offer

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Santhera Reports Interim Results on Convertible Bond Exchange Offer Santhera Pharmaceuticals Holding AGApril 20, 2021 GMT NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, April 20, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that so far an aggregate principal value of around CHF 39.6 million, or 66% of its CHF 60 Million Convertible Bonds, have been accepted for exchange under the Exchange Offer announced on March 25, 2021. Bondholders who have not yet accepted the Exchange Offer will be able to do so during the additional acceptance period ending on April 27, 2021, 5:00 p.m. CEST. In parallel to the Exchange Offer, voting on the bondholders’ resolution continues.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.